Value-Based Pricing in Malaysia's Healthcare: A stakeholder analysis
Background: High pharmaceutical price is a dilemma. Value-based pricing (VBP) is suggested to be the potential solution to this problem. However, in Malaysia, VBP does not receive favorable response from the industry players. Therefore, in this study we would like to examine the position of various...
Saved in:
Main Authors: | Amirul Ashraf (Author), Siew Chin Chin Ong (Author) |
---|---|
Format: | Book |
Published: |
ACHSM,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Malaysia healthcare system: Protect the public or the industry?
by: Amirul Ashraf, et al.
Published: (2021) -
Cost-effectiveness of adding empagliflozin to the standard of care for patients with heart failure with reduced ejection fraction from the perspective of healthcare system in Malaysia
by: Siew Chin Ong, et al.
Published: (2023) -
Pharmacists' interventions on prescribing errors in Malaysia
by: Zhi Shan Sujata Tan, et al.
Published: (2024) -
Drug Utilization and Drug Pricing in the Private Primary Healthcare System in Malaysia: An Employer Price Control Mechanism
by: Che Suraya Zin, et al.
Published: (2020) -
Association between medicine Price declaration by pharmaceutical industries and retail prices in Malaysia's private healthcare sector
by: Nur Sufiza Ahmad, et al.
Published: (2019)